Offer - Urjas Oil for just ₹ 1
Glizid Total P is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Diabetes Type 2, Diabetes Type 2, Diabetes. Secondary and off-label uses of Glizid Total P have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Glizid Total P. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Glizid Total P include Constipation, Abdominal Pain, Indigestion. Apart from the aforementioned side effects, Glizid Total P can also lead to other problems, which have been listed below. Normally, these side effects of Glizid Total P are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Glizid Total P has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Glizid Total P related warnings talks about Glizid Total P's effects on the liver, heart and kidney.
Glizid Total P is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Liver Disease, Diabetic Ketoacidosis are examples of such conditions. Some other conditions that can be affected by Glizid Total P are listed in the contraindications section below.
Besides this, Glizid Total P may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Glizid Total P is safe while driving, and is addiction.
Glizid Total P is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Glizid Total P safe for pregnant women?
Pregnant women can consume [medicine]. Though Glizid Total P has mild side effects when taken during pregnany
Is the use of Glizid Total P safe during breastfeeding?
Breastfeeding women may feel side effects of Glizid Total P. If you see any side effects, stop taking Glizid Total P immediately and talk to your doctor. Take Glizid Total P again, only after your doctor's advice.
What is the effect of Glizid Total P on the Kidneys?
Glizid Total P is not harmful for kidneys.
What is the effect of Glizid Total P on the Liver?
Glizid Total P is completely safe for the liver.
What is the effect of Glizid Total P on the Heart?
There are no any side effects of Glizid Total P for the heart.
Glizid Total P should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glizid Total P unless your doctor advises you to do so -
Is this Glizid Total P habit forming or addictive?
Forming a habit of Glizid Total P has not been reported.
Interaction between Food and Glizid Total P
Due to a lack of research, nothing can be said about the consequences of taking Glizid Total P together with food.
Interaction between Alcohol and Glizid Total P
Consuming Glizid Total P with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826